UCSF Psychiatry News

The 17th Robert S. Wallerstein, MD Lectureship in Psychoanalysis and Psychotherapy, featuring UCSF clinician-researcher Mardi Horowitz, MD, will be held on Wednesday, April 12, 2023.

Four early career researchers from the UCSF Weill Institute for Neurosciences have been selected to present their scholarship and research at Department of Psychiatry and Behavioral Sciences Grand Rounds events later this spring as part of a series designed to highlight the work of senior trainees at or near the end of their training and help launch their academic careers.

The UCSF Department of Psychiatry and Behavioral Sciences retained its position as third among departments at public institutions and 10th among all recipients in psychiatric research grants from the National Institutes of Health (NIH) in fiscal year 2022, according to annual figures released by the independent Blue Ridge Institute for Medical Research (BRIMR).

UCSF's Marina Tolou-Shams, PhD, reflected on her career journey and research agenda on the latest episode of the National Institute of Health’s Women Leading Prevention Science podcast.

Longtime UC San Francisco clinical professor David R. Kessler, MD, died on November 24, 2022, following a long illness at the age of 92.

A new study shows that sleep medications increase the risk of dementia for people who are white—but the type and quantity of the medication may be factors in explaining the higher risk.

Turning a decades-old dogma on its head, new research shows that the receptor for oxytocin, a hormone considered essential to forming social bonds, may not play the critical role that scientists have assigned to it for the past 30 years.

A conversation with Ellen Herbst, MD, a UCSF psychiatrist and mother of two, about how the climate crisis is impacting the mental health of children and adolescents — and what parents can do to help.

Researchers at UCSF and other institutions around the world are finding that once-villainized substances show promise in treating a remarkably wide range of mental health disorders, including post-traumatic stress disorder, depression, and addiction.

A new study from researchers at UCSF and the San Francisco VA Medical Center shows how wrist-activity biomarkers could have utility as screening tools for adverse symptom outcomes after trauma exposure.